Repro Med Systems Stock Price and Value Analysis

Should you buy Repro Med Systems stock? (OTC:REPR). Let's see how it does in our automated value investing analysis system.

REPR Free Cash Flow Trend

Free Cash Flow trendline for REPR
Free Cash Flow trendline for Repro Med Systems

Hmm, we can't give any reliable projection for Repro Med Systems's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

AdvantagesDisadvantagesNeutral
  • This company has amazingly consistent growth!
  • This stock looks overpriced.
  • This company is less known than others.
  • This company is not making money.
  • This company pays no dividend.

Inside the REPR Numbers

REPR Price
(Repro Med Systems stock price per share)
$3.31
[?] PE Ratio versus Sector 1941% higher than other Healthcare stocks
[?] PE Ratio versus Industry 1616% higher than other Medical Instruments & Supplies stocks
[?] Free Cash Flow Jitter 11%

Is Repro Med Systems Stock on Sale?

Based on our analysis, we believe that you should not buy Repro Med Systems right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy REPR Stock?

Does Repro Med Systems have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.